Gestrinone (R2323) Binding to Steroid Receptors in Human Uterine Endometrial Cytosol

T Tamaya, Tamaya T, Jiro Fujimoto, Fujimoto J, J Fujimoto, Y Watanabe, Yoshiyuki Watanabe, Watanabe Y, Kenji Arahori, K Arahori, Arahori K, Okada H, H Okada, Hiroji Okada
Acta obstetricia et gynecologica Scandinavica · 1986 · vol. 65(5) , pp. 439–441 · doi:10.3109/00016348609157380 · PMID:3490730 · W2007835670
article OA: closed CC0 ⤵ 7 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-28 ⓘ

Gestrinone binds to human endometrial estrogen, progesterone, and androgen receptors, occupying all specific steroid binding sites, which may relate to its therapeutic effects in endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

To understand the mechanism of biological action of gestrinone (R2323), which has a therapeutic effect against endometriosis, the binding of gestrinone to numerous classes of intracellular steroid binding proteins was studied in the human uterine endometrium. Gestrinone bound to endometrial receptors for estrogen, progesterone and androgen, but seemed not to bind to endometrial intracellular corticosteroid-binding globulin and sex hormone-binding globulin. Gestrinone occupies all specific binding sites of steroids in the steroid target cells despite the presence of endogenous steroids. It is speculated that the binding behavior of gestrinone may be related to its therapeutic effect on endometriosis. Gestrinone's more avid affinity for estrogen receptor may be the reason for the ability to use a lower clinical dose of gestrinone.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cytosol Endometrium Gestrinone Norpregnatrienes Receptors, Steroid Cytosol Endometrium Estradiol Estradiol Estrenes Estrenes Female Gestrinone Humans Metribolone Norpregnatrienes Promegestone Promegestone Receptors, Steroid

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (12)

Cited by (7)

Source provenance

europepmc
last seen: 2026-07-29T06:27:48.050232+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:40.384591+00:00
License: CC0 · commercial use OK